Sterling Pharma Solutions

Information

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years' experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling has four facilities employing more than 800 people. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

Exhibitor Access Type

In-person & Online

Sub-event

CPhI

Country

[object Object]

Organization Type

Manufacturer/Innovator

Markets Active In

North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countries

Booth Location

7H51

Offering

Offering: Products or Services

Custom ManufacturingIntermediates, Fine and Specialty ChemicalsContract Services

Offering: Contract Services

ChromatographyMethod DevelopmentMethod ValidationQuality Control TestingStability TestingAnalytical DevelopmentContract ManufacturingDevelopment & Validation of Analytical MethodsDrug DiscoveryProcess OptimisationSynthetic Organic ChemistrySynthetic Route DesignChemical synthesis/analysis

Offering: Custom Manufacturing

API Contract ManufacturingExclusive Synthesis of APIsCustom Manufacturing (general category)Custom Manufacturing/Exclusive Synthesis of Fine Chemicals

Offering: Intermediates, Fine and Specialty Chemicals

Advanced IntermediatesChiral Intermediates

Social media

Contact details